Free Virtual Consultations. Corona Virus Related Cases Click Here.

Claudia Lucrey Killed in Motorcycle Crash on Interstate 215 Near Cactus Avenue

Motorcycle, SUV Collide in Fatal Moreno Valley Accident

Fatal Accident 3
Fatal Accident 3

Moreno Valley, CA (March 10, 2020) – A woman was killed in a motorcycle crash in Moreno Valley. The fatal accident occurred on the evening of March 10 on Interstate 215.

A motorcycle and a Toyota Highlander collided on Interstate 215 near Cactus Avenue. The motorcyclist, Claudia Lucrey, 29, died at the accident scene. The driver of the Toyota Highlander remained at the crash site.

Our heartfelt condolences go out to the friends and loved ones of Claudia Lucrey.

#Moreno Valley


December 2, 2019

1 Killed in Crash on Interstate 8 at El Cajon Boulevard

2 Vehicles Involved in Fatal El Cajon Accident...

October 3, 2019

Woman Injured in Hit and Run Crash on State Route 67 Near Dye Road

Bicyclist Airlifted to Hospital in Ramona Accident Ramona, CA (October 2, 2019)...

October 7, 2019

Child Hospitalized After Crash on Dinah Shore Drive

2 Vehicles Collide in Rollover Accident in Rancho Mirage Rancho Mirage, CA (Oct...

Free Police Report Request

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.

What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.

Why Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post

May 22, 2020

Johnson & Johnson Discontinues Talc-Based Baby Powder

baby powder new Johnson & Johnson discontinued its talc-based baby powders in the United States and Canada because thousands of lawsuits claiming it was contaminated with asbestos created a sales decline.

May 18, 2020

FDA Issues Warnings To Two Manufacturers Of Breast Implants

The U.S. Food and Drug Administration (FDA) just issued warning letters to two manufacturers of breast implants for failing to comply with regulatory requirements. The FDA sent a warning letter to Allergan for failure to comply with requirements to conduct post-approval studies assessing the risks and long-term safety of two separate breast implant models. Both breast implant models were voluntarily recalled last year. The FDA also sent a warning letter to Ideal Implant Incorporated. That letter was sent for failing to comply with adverse event reporting requirements and current good manufacturing practice requirements. The letter was prompted by an inspection which was conducted earlier in 2020.